Clinical Trial Detail

NCT ID NCT02190695
Title A Safety and Efficacy Study Using Decitabine, Decitabine/Carboplatin, Decitabine/Arsenic for the Treatment of Relapsed, Refractory, and Elderly Acute Myeloid Leukemia , Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Temple University
Indications

acute myeloid leukemia

Therapies

Carboplatin + Decitabine

Arsenic trioxide + Decitabine

Age Groups: adult

No variant requirements are available.